Siemens Healthineers Weighs Sale, Carve-Out of Diagnostics Unit, Bloomberg Reports
--Siemens Healthineers is considering strategic options for its diagnostics business, which could be valued at up to $8 billion, with a sale or carve-out among the scenarios being considered, Bloomberg reports, citing unnamed sources.
--The review, which seeks to streamline the German healthcare group's operations, is at an early stage and the company could still opt to keep the assets, but the business would likely attract interest from private-equity groups, according to Bloomberg.
--Siemens Healthineers didn't respond to a request for comment when contacted by Dow Jones Newswires.
Full story: https://shorturl.at/fkpsA
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
November 03, 2023 03:41 ET (07:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks